Ankur Patel, DO
Pain Medicine · Holly Springs, NCNPI 1215428933
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (35.5%), grants and food and beverage — rather than concentrated in one kind of arrangement. Medtronic accounts for 82.2% of it on its own, with 5 other manufacturers making up the rest. Reporting peaked in 2022 at $4,583 and has fallen 98.3% since, to $80 in 2025.
Across 59 payments — averaging $129.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$6K
- Boston Scientific$746
- Nevro Corp.$392
- AbbVie$119
- Abbott$80
- Teva Pharmaceuticals USA, Inc.$26
What the payments were for
- Grants$2,50033%
- Travel & lodging$2,71836%
- Food & beverage$2,43832%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 37 | $6,293 |
| Boston Scientific | 13 | $746 |
| Nevro Corp. | 5 | $392 |
| AbbVie | 2 | $119 |
| Abbott | 1 | $80 |
| Teva Pharmaceuticals USA, Inc. | 1 | $26 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$7,656 in reported general payments places this provider in the 65th percentile of 182 pain medicine providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Methocarbamol | 169 | $2,454 |
| Naloxone Hcl | 28 | $1,607 |
| Gabapentin | 160 | $1,551 |
| Cyclobenzaprine Hcl | 55 | $1,184 |
| Lidocaine | 16 | $1,021 |
| Pregabalin | 40 | $950 |
| Tizanidine Hcl | 66 | $798 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 22 | $756 |
| Celecoxib | 22 | $599 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 22 | $524 |
| Duloxetine Hcl | 38 | $359 |
| Baclofen | 17 | $274 |
| Tramadol Hcl | 14 | $81 |
Paid to pharmacies, not to this prescriber.
Other pain medicine in Holly Springs
- James NorthWinston Salem$721K
- Leonardo KapuralWinston Salem$523K
- Christopher GilmoreWinston Salem$457K
- Richard RauckWinston Salem$431K
- Courtney AumanJacksonville$186K
- Jacob WangCharlotte$162K
- Aashish KumarCharlotte$160K
- Javid BakshAsheville$116K
- David ZubLeland$97K
- James DeeringCharlotte$93K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.